Dana-Farber Retractions: Meet the Blogger Who Spotted Problems in Dozens of Cancer Papers

The prestigious Dana-Farber Cancer Institute (DFCI) acknowledged that it would seek retractions for 6 papers and corrections for an additional 31 — some co-authored by DFCI chief executive Laurie Glimcher, chief operating officer William Hahn, and several other prominent cancer researchers.